160 related articles for article (PubMed ID: 22607473)
1. Tight-binding inhibitors efficiently inactivate both reaction centers of monomeric Plasmodium falciparum glyoxalase 1.
Urscher M; More SS; Alisch R; Vince R; Deponte M
FEBS J; 2012 Jul; 279(14):2568-78. PubMed ID: 22607473
[TBL] [Abstract][Full Text] [Related]
2. Allosteric coupling of two different functional active sites in monomeric Plasmodium falciparum glyoxalase I.
Deponte M; Sturm N; Mittler S; Harner M; Mack H; Becker K
J Biol Chem; 2007 Sep; 282(39):28419-28430. PubMed ID: 17664277
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
Akoachere M; Iozef R; Rahlfs S; Deponte M; Mannervik B; Creighton DJ; Schirmer H; Becker K
Biol Chem; 2005 Jan; 386(1):41-52. PubMed ID: 15843146
[TBL] [Abstract][Full Text] [Related]
4. Distinct subcellular localization in the cytosol and apicoplast, unexpected dimerization and inhibition of Plasmodium falciparum glyoxalases.
Urscher M; Przyborski JM; Imoto M; Deponte M
Mol Microbiol; 2010 Apr; 76(1):92-103. PubMed ID: 20149108
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic and antimalarial effects of tight-binding glyoxalase 1 inhibitors on the host-parasite unit of erythrocytes infected with Plasmodium falciparum.
Wezena CA; Urscher M; Vince R; More SS; Deponte M
Redox Biol; 2016 Aug; 8():348-53. PubMed ID: 26972115
[TBL] [Abstract][Full Text] [Related]
6. The glyoxalase pathway in protozoan parasites.
Sousa Silva M; Ferreira AE; Gomes R; Tomás AM; Ponces Freire A; Cordeiro C
Int J Med Microbiol; 2012 Oct; 302(4-5):225-9. PubMed ID: 22901378
[TBL] [Abstract][Full Text] [Related]
7. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Toxoplasma gondii glyoxalase 1 and evaluation of inhibitory effects of curcumin on the enzyme and parasite cultures.
Goo YK; Yamagishi J; Ueno A; Terkawi MA; Aboge GO; Kwak D; Hong Y; Chung DI; Igarashi M; Nishikawa Y; Xuan X
Parasit Vectors; 2015 Dec; 8():654. PubMed ID: 26694921
[TBL] [Abstract][Full Text] [Related]
9. The glyoxalase system of malaria parasites--implications for cell biology and general glyoxalase research.
Urscher M; Alisch R; Deponte M
Semin Cell Dev Biol; 2011 May; 22(3):262-70. PubMed ID: 21310259
[TBL] [Abstract][Full Text] [Related]
10. Glyoxalase I of the malarial parasite Plasmodium falciparum: evidence for subunit fusion.
Iozef R; Rahlfs S; Chang T; Schirmer H; Becker K
FEBS Lett; 2003 Nov; 554(3):284-8. PubMed ID: 14623080
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO.
Dufe VT; Qiu W; Müller IB; Hui R; Walter RD; Al-Karadaghi S
J Mol Biol; 2007 Oct; 373(1):167-77. PubMed ID: 17822713
[TBL] [Abstract][Full Text] [Related]
12. A metabolically stable tight-binding transition-state inhibitor of glyoxalase-I.
More SS; Vince R
Bioorg Med Chem Lett; 2006 Dec; 16(23):6039-42. PubMed ID: 16997560
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophore.
Takasawa R; Tao A; Saeki K; Shionozaki N; Tanaka R; Uchiro H; Takahashi S; Yoshimori A; Tanuma S
Bioorg Med Chem Lett; 2011 Jul; 21(14):4337-42. PubMed ID: 21669529
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by active site directed covalent modification of human glyoxalase I.
Holewinski RJ; Creighton DJ
Bioorg Med Chem; 2014 Jul; 22(13):3301-8. PubMed ID: 24856185
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis.
Urscher M; Deponte M
Biol Chem; 2009 Nov; 390(11):1171-83. PubMed ID: 19663684
[TBL] [Abstract][Full Text] [Related]
16. Novel bivalent inhibitors with sub-nanomolar affinities towards human glyoxalase I.
Sang Y; Shi Q; Mo M; Ni C; Li Z; Liu B; Deng Q; Creighton DJ; Zheng ZB
Bioorg Med Chem Lett; 2015 Nov; 25(21):4724-4727. PubMed ID: 26320622
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors.
More SS; Vince R
J Med Chem; 2009 Aug; 52(15):4650-6. PubMed ID: 19610604
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum avoids change in erythrocytic surface expression of phagocytosis markers during inhibition of nitric oxide synthase activity.
Hempel C; Kohnke H; Maretty L; Jensen PØ; Staalsø T; Kurtzhals JA
Mol Biochem Parasitol; 2014 Nov; 198(1):29-36. PubMed ID: 25454716
[TBL] [Abstract][Full Text] [Related]
19. Discovery of covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase, a target for the treatment of malaria.
Bruno S; Pinto A; Paredi G; Tamborini L; De Micheli C; La Pietra V; Marinelli L; Novellino E; Conti P; Mozzarelli A
J Med Chem; 2014 Sep; 57(17):7465-71. PubMed ID: 25137375
[TBL] [Abstract][Full Text] [Related]
20. Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies.
Yuan M; Luo M; Song Y; Xu Q; Wang X; Cao Y; Bu X; Ren Y; Hu X
Bioorg Med Chem; 2011 Feb; 19(3):1189-96. PubMed ID: 21237663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
